Sclerosis, Multiple
14
4
5
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
14.3%
2 terminated out of 14 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (14)
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
French Registry for Monitoring Pregnancies for Multiple Sclerosis
Effects of Blood Flow Restriction Training on Middle-aged People With Multiple Sclerosis.
The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
Application of ihMT MRI in Multiple Sclerosis
The Efficacy of Tele Rehabilitation- Based Task-Specific Training for Cognitive Function Improvement
EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2)
Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients
EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2)
Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?
Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
XO as a Screening Test of Cognitive Impairment in Multiple Sclerosis
Aerobic Exercise and Transcranial Low Laser Therapy in Patients With Central Nervous System Injury
Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis